Organicell Regenerative Medicine
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Organicell Regenerative Medicine's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 30% to $4,558,278. The net income raised on -$6,986,708 and profit margin reached -153%. Total operating expenses were $10,817,627.

Profit Margin

Organicell Regenerative Medicine, Inc. (OTC:OCEL): Profit margin
2014 49.19K -65.81K -133.78%
2015 147.62K -738.35K -500.14%
2016 184.88K -1.25M -677.84%
2017 569.84K -8.97M -1574.49%
2018 964.53K -3.46M -358.95%
2019 1.70M -1.86M -109.78%
2020 3.05M -12.79M -418.66%
2021 5.59M -12.81M -229.03%
2022 6.49M -8.95M -137.89%
2023 4.55M -6.98M -153.28%

OCEL Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
4.55M6.49M5.59M3.05M1.70M964.53K569.84K184.88K147.62K49.19K
Cost of revenue
507.62K753.53K547.88K398.60K300.83K209.29K160.62K94.40K49.41K20.05K
Gross profit
4.05M5.73M5.04M2.65M1.40M755.23K409.21K90.47K98.21K29.13K
Operating exp.
Research and development
922.7K791.32K1.12M233.52K54.86K00000
Selling and marketing
0000000000
Total operating expenses
10.81M14.58M17.79M15.09M3.17M4.24M9.05M1.13M861.09K94.95K
Operating income
-6.76M-8.84M-12.74M-12.43M-1.77M-3.49M-8.64M-1.04M-762.88K-65.81K
Other income (expenses), net
-219.73K-53.59K-12.45K-145.02K38.19K287.02K-470.99K-12.72K787.40K0
Income before tax
-6.98M-8.89M-12.75M-12.58M-1.73M-3.43M-9.11M-1.05M-762.88K-65.81K
Income tax expense
402.50K53.59K63.41K210.46K130.41K-234.86K-236.35K197.15K-24.52K0
Net income
-6.98M-8.95M-12.81M-12.79M-1.86M-3.46M-8.97M-1.25M-738.35K-65.81K
Earnings per share
Basic EPS
-0.99-1.57-2.42-3.81-0.8-2.55-16-2-2-2
Diluted EPS
-0.99-1.57-2.42-3.81-0.8-2.55-16-2-2-2
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source